John Kaiser
2016 - Avalo Therapeutics
In 2016, John Kaiser earned a total compensation of $450.4K as Former Chief Business Officer and interim Chief Executive Officer at Avalo Therapeutics, a 10% decrease compared to previous year.
Compensation breakdown
| Option Awards | $153,411 |
|---|---|
| Salary | $297,000 |
| Total | $450,411 |
Kaiser received $297K in salary, accounting for 66% of the total pay in 2016.
Kaiser also received $153.4K in option awards.
Rankings
In 2016, John Kaiser's compensation ranked 11,543rd out of 14,075 executives tracked by ExecPay. In other words, Kaiser earned more than 18.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,543 out of 14,075 | 18th |
Division Manufacturing | 4,498 out of 5,489 | 18th |
Major group Chemicals And Allied Products | 1,610 out of 1,895 | 15th |
Industry group Drugs | 1,303 out of 1,538 | 15th |
Industry Pharmaceutical Preparations | 1,012 out of 1,176 | 14th |
Source: SEC filing on April 5, 2018.
Kaiser's colleagues
We found three more compensation records of executives who worked with John Kaiser at Avalo Therapeutics in 2016.